Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq)

AIDS Research and Human Retroviruses

Volumn 24, Issue 9, 2008, Pages 1209-1213

  Towler, William Ian ^a   Church, Jessica D ^a   Eshleman, James R ^a   Fowler, Mary Glenn ^a   Guay, Laura A ^a   Jackson, J Brooks ^a   Eshleman, Susan H ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEVIRAPINE; RNA DIRECTED DNA POLYMERASE;

ARTICLE; BACTERIUM COLONY; BLOOD SAMPLING; CLINICAL ARTICLE; CODON; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC LINKAGE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UGANDA;

AMINO ACID SUBSTITUTION; ANTI-HIV AGENTS; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NEVIRAPINE; PLASMA; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; UGANDA;

EID: 51849114315     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0109     Document Type: Article

References (16)

1. McConnell MS, Stringer JS, Kourtis AP, Weidle PJ, and Eshleman SH: Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: Does development of resistance matter? Am J Obstet Gynecol 2007;197:S56-63.
2. Flys TS, Donnell D, Mwatha A, et al.: Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission. J Infect Dis 2007;195:711-715.
3. Johnson J, Li JF, Wei X, et al.: Low-frequency mutations substantially increase the prevalence of transmitted drug resistance and greatly strengthen the relationship between resistance mutations and virologic failure. 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, CA, February 25-28, 2007, Abstract #639.
4. Ellis GM, Mahalanabis M, Beck IA, et al.: Comparison of oligonucleotide ligation assay and consensus sequencing for detection of drug-resistant mutants of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and plasma. J Clin Microbiol 2004;42:3670-3674.
5. Palmer S, Boltz V, Martinson N, et al.: Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission. Proc Natl Acad Sci USA 2006;103:7094-7099.
6. Eshleman SH, Jones D, Flys T, Petrauskene O, and Jackson JB: Analysis of HIV-1 variants by cloning DNA generated with the ViroSeq HIV-1 Genotyping System. Biotechniques 2003;35:614-618, 620, 622.
7. Palmer S, Kearney M, Maldarelli F, et al.: Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol 2005;43:406-413.
8. Hoffmann C, Minkah N, Leipzig J, et al.: DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations. Nucleic Acids Res 2007;35:e91.
9. Cai F, Chen H, Hicks CB, Bartlett JA, Zhu J, and Gao F: Detection of minor drug-resistant populations by parallel allele-specific sequencing. Nat Methods 2007;4:123-125.
10. Murphy KM, Berg KD, and Eshleman JR: Sequencing of genomic DNA by combined amplification and cycle sequencing reaction. Clin Chem 2005;51:35-39.
11. Guay LA, Musoke P, Fleming T, et al.: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
12. Jackson JB, Musoke P, Fleming T, et al.: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18 months follow-up of the HIVNET 012 randomised trial. Lancet 2003;362:859-868.
13. McConnell MS, Bakaki P, Eure C, et al.: Effectiveness of repeat single-dose nevirapine for prevention of mother-to-child transmission of HIV-1 in repeat pregnancies, Uganda. J Acquir Immune Defic Syndr 2007;46:291-296.
14. Hall TA. BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999;41:95-98.
15. Stanford University: Stanford University HIV Drug Resistance Database. http://hivdb.stanford.edu/cgi-bin/NNR-TIResiNote. cgi: Accessed 04/08.
16. Parkin NT, Gupta S, Chappey C, and Petropoulos CJ: The K101P and K103R/V179D mutations in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nonnucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother 2006;50:351-354.